Participants who initiated long-acting cabotegravir-rilpivirine had a high rate of adherence and virologic suppression, with ...

Researchers found that lenacapavir reduced almost 100% reduction new HIV infections among participants who received it as a ...

Popular global HIV/AIDS program PEPFAR has been spared as Congress passes a package with billions of dollars in spending cuts ...

Thousands of adults age 50-plus are diagnosed with HIV every year, but an expanding menu of medications can help prevent ...

The program known as PEPFAR is one of the most effective and popular U.S. foreign aid projects in history, and the government ...

In a letter, the Long Beach Democrat asked Health and Human Services Secretary Robert F. Kennedy Jr. to produce documents ...

The investigational oral pre-exposure prophylaxis (PrEP) agent MK-8527 showed a similar, well-tolerated safety profile to ...

South Africa's government has estimated that universities and science councils could lose about $107 million in U.S. research ...

The World Health Organization on Monday recommended Gilead's lenacapavir, a twice-yearly injection, as a tool to prevent HIV ...

The World Health Organisation (WHO) released new guidelines recommending the use of injectable lenacapavir (LEN) twice a year ...

Two monoclonal antibodies appeared safe and tolerable when administered alone or in combination to newborns exposed to HIV, according to a proof-of-concept study presented at the International AIDS ...

This groundbreaking HIV initiative designed to meet Black and LGBTQ+ communities where they are — spiritually, culturally, ...